Clinical Trials Directory

Trials / Completed

CompletedNCT01397032

Attention Bias Modification Treatment for Children With Social Anxiety

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
67 (actual)
Sponsor
Tel Aviv University · Academic / Other
Sex
All
Age
7 Years – 18 Years
Healthy volunteers
Not accepted

Summary

Children with social anxiety will be randomly assigned to either Attention Bias Modification Treatment (ABMT) designed to direct attention away from threat or a placebo control condition not designed to change attention patterns. Outcome measures will be depression and social anxiety symptoms as measured by gold standard questionnaires as well as diagnosis of social phobia disorder and symptom counts derived from structured clinical interviews with children and their parents. We expect to see significant reduction in social anxiety symptoms in the Attention Bias Modification Treatment (ABMT) group relative to the placebo control group.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAttention Bias Modification Treatment (ABMT)Behavioral: Attention Bias Modification Treatment (ABMT) Attention training using a computerized spatial attention task (dot-probe) modified to alter threat-related attention patterns.
BEHAVIORALAttention Control ConditionAttention training using a computerized spatial attention task (dot-probe) not intended to alter threat-related attention patterns.

Timeline

Start date
2011-04-01
Primary completion
2014-08-01
Completion
2014-08-01
First posted
2011-07-19
Last updated
2015-05-27

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01397032. Inclusion in this directory is not an endorsement.